Veradigm (NASDAQ:MDRX – Free Report) had its price objective decreased by TD Cowen from $26.00 to $15.00 in a research report released on Tuesday morning, Benzinga reports. TD Cowen currently has a buy rating on the software maker’s stock. MDRX has been the subject of several other research reports. Deutsche Bank Aktiengesellschaft reaffirmed a hold […]